Lisa S. Millar

2.0k total citations
23 papers, 1.6k citations indexed

About

Lisa S. Millar is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Rheumatology. According to data from OpenAlex, Lisa S. Millar has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in Lisa S. Millar's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Lisa S. Millar is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Lisa S. Millar collaborates with scholars based in United States, Germany and United Kingdom. Lisa S. Millar's co-authors include Stephen D. Mikolajczyk, Harry G. Rittenhouse, Abhay Kumar, S D Mikolajczyk, Mohammad S. Saedi, Leonard S. Marks, Kevin M. Slawin, Kathy M. Marker, Cindy L. Evans and Weitao Song and has published in prestigious journals such as European Journal of Biochemistry, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

Lisa S. Millar

22 papers receiving 1.5k citations

Peers

Lisa S. Millar
Judith A. Finlay United States
Zuxiong Chen United States
Sunita R. Setlur United States
Remedios Penetrante United States
Colin Cooper United Kingdom
G Sauter United States
Sze Ting Lee Australia
Colin Marsh United Kingdom
Judith A. Finlay United States
Lisa S. Millar
Citations per year, relative to Lisa S. Millar Lisa S. Millar (= 1×) peers Judith A. Finlay

Countries citing papers authored by Lisa S. Millar

Since Specialization
Citations

This map shows the geographic impact of Lisa S. Millar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa S. Millar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa S. Millar more than expected).

Fields of papers citing papers by Lisa S. Millar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa S. Millar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa S. Millar. The network helps show where Lisa S. Millar may publish in the future.

Co-authorship network of co-authors of Lisa S. Millar

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa S. Millar. A scholar is included among the top collaborators of Lisa S. Millar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa S. Millar. Lisa S. Millar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kollert, Florian, Jason Neale, Nicolas Frances, et al.. (2024). AB1034 CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annals of the Rheumatic Diseases. 83. 1837–1838.
2.
Mikolajczyk, Stephen D., Lisa S. Millar, Stephen M. Coutts, et al.. (2011). Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood. Journal of Oncology. 2011. 1–10. 215 indexed citations
3.
Mikolajczyk, Stephen D., William J. Catàlona, Cindy L. Evans, et al.. (2004). Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer. Clinical Chemistry. 50(6). 1017–1025. 117 indexed citations
4.
Linton, Harry J., Leonard S. Marks, Lisa S. Millar, et al.. (2003). Benign Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease. Clinical Chemistry. 49(2). 253–259. 85 indexed citations
5.
Millar, Lisa S., et al.. (2001). Deletion of the cnxE gene encoding the gephyrin-like protein involved in the final stages of molybdenum cofactor biosynthesis in Aspergillus nidulans. Molecular Genetics and Genomics. 266(3). 445–453. 20 indexed citations
6.
Finlay, Judith A., John Day, Cindy L. Evans, et al.. (2001). Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2. Clinical Chemistry. 47(7). 1218–1224. 18 indexed citations
7.
Mikolajczyk, S D, Kathy M. Marker, Lisa S. Millar, et al.. (2001). A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.. PubMed. 61(18). 6958–63. 156 indexed citations
8.
Slawin, Kevin M., et al.. (2000). Benign prostatic hyperplasia‐associated prostate‐specific antigen (BPSA) shows unique immunoreactivity with anti‐PSA monoclonal antibodies. European Journal of Biochemistry. 267(13). 4040–4045. 30 indexed citations
9.
Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (2000). Seminal plasma contains ?BPSA,? a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia. The Prostate. 45(3). 271–276. 46 indexed citations
10.
Kumar, Abhay, Stephen D. Mikolajczyk, Timothy Hill, Lisa S. Millar, & Mohammad S. Saedi. (2000). Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells. The Prostate. 44(3). 248–254. 36 indexed citations
11.
Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (2000). Seminal plasma contains “BPSA,” a molecular form of prostate‐specific antigen that is associated with benign prostatic hyperplasia. The Prostate. 45(3). 271–276. 3 indexed citations
12.
Mikolajczyk, Stephen D., Lisa S. Millar, Harry G. Rittenhouse, et al.. (2000). “BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Urology. 55(1). 41–45. 135 indexed citations
13.
Mikolajczyk, S D, Lisa S. Millar, Harry G. Rittenhouse, et al.. (2000). A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.. PubMed. 60(3). 756–9. 142 indexed citations
14.
Mikolajczyk, Stephen D., Lisa S. Millar, Abhay Kumar, & Mohammad S. Saedi. (1999). Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1. International Journal of Cancer. 81(3). 438–442. 61 indexed citations
15.
Mikolajczyk, Stephen D., et al.. (1999). Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor‐1. International Journal of Cancer. 81(3). 438–442. 4 indexed citations
16.
Mikolajczyk, Stephen D., Lisa S. Millar, Abhay Kumar, & Mohammad S. Saedi. (1998). Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. The Prostate. 34(1). 44–50. 54 indexed citations
18.
Mikolajczyk, Stephen D., et al.. (1998). Human glandular kallikrein, hK2, shows arginine‐restricted specificity and forms complexes with plasma protease inhibitors. The Prostate. 34(1). 44–50. 4 indexed citations
19.
Mikolajczyk, Stephen D., Lisa S. Millar, Kathy M. Marker, et al.. (1997). Ala217 is Important for the Catalytic Function and Autoactivation of Prostate‐Specific Human Kallikrein 2. European Journal of Biochemistry. 246(2). 440–446. 51 indexed citations
20.
Mikolajczyk, Stephen D., Lana S. Grauer, Lisa S. Millar, et al.. (1997). A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology. 50(5). 710–714. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026